A Dark Vector Cognition product

Item 6. EXHIBITS

11K characters. Original on sec.gov ·

Item 6. EXHIBITS

The 4 tables in Item 6. EXHIBITS as one CSV, figures in aligned columns. For subscribers: paste your API key. One API call. Plans from $19 a month, see pricing.

Incorporated by Reference
Exhibit NumberExhibit DescriptionFormFile No.Date of First FilingExhibit NumberProvided Herewith
10.01*Amendment Number Sixteen to Amended and Restated Non-Exclusive Distribution Agreement, dated September 1, 2023, by and between DexCom, Inc. and Byram Healthcare Centers, Inc.————X
10.02*Amendment Number Thirteen to Non-Exclusive Distribution Agreement, dated September 1, 2023, by and between DexCom, Inc. and RGH Enterprises, LLC.————X
31.01Certification of Chief Executive Officer Pursuant to Securities Exchange Act Rule 13a-14(a).————X
31.02Certification of Chief Financial Officer Pursuant to Securities Exchange Act Rule 13a-14(a).————X
32.01**Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350 and Securities Exchange Act Rule 13a-14(b).————X
32.02**Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350 and Securities Exchange Act Rule 13a-14(b).————X
101.INSXBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL documentX
101.SCHInline XBRL Taxonomy Extension Schema DocumentX
101.CALInline XBRL Taxonomy Extension Calculation Linkbase DocumentX
101.DEFInline XBRL Taxonomy Extension Definition Linkbase DocumentX
101.LABInline XBRL Taxonomy Extension Label Linkbase DocumentX

Table of Contents

Incorporated by Reference
Exhibit NumberExhibit DescriptionFormFile No.Date of First FilingExhibit NumberProvided Herewith
101.PREInline XBRL Taxonomy Extension Presentation Linkbase DocumentX
104Cover Page Interactive Data File - the cover page from the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 is formatted in Inline XBRLX
*Portions of this exhibit have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K.
**This certification is not deemed “filed” for purposes of Section 18 of the Securities Exchange Act, or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except to the extent that Dexcom specifically incorporates it by reference.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

DEXCOM, INC. (Registrant)
Dated:October 26, 2023By:/s/ KEVIN R. SAYER
Kevin R. Sayer, Chairman of the Board of Directors, President and Chief Executive Officer (Principal Executive Officer)
Dated:October 26, 2023By:/s/ JEREME M. SYLVAIN
Jereme M. Sylvain, Executive Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)

Previous: Item 5. OTHER INFORMATION